Skip to content
2000
Volume 23, Issue 26
  • ISSN: 1385-2728
  • E-ISSN: 1875-5348

Abstract

Rapid tumor growth is dependent on the capability of tumor blood vessels and glycolysis to provide oxygen and nutrients. Tumor hypoxia is a common characteristic of many solid tumors, and it essentially happens when the growth of the tumor exceeds the concomitant angiogenesis. Hypoxia-inducible factor 1 (HIF-1) as the critical transcription factor in hypoxia regulation is activated to adapt to this hypoxia situation. Flavonoids, widely distributed in plants, comprise many polyphenolic secondary metabolites, possessing broadspectrum pharmacological activities, including their potentiality as anticancer agents. Due to their low toxicity, intense efforts have been made for investigating natural flavonoids and their derivatives that can be used as HIF-1α inhibitors for cancer therapy during the past few decades. In this review, we sum up the findings concerning the inhibition of HIF-1α by natural flavonoids in the last few years and propose the idea of designing tumor vascular and glycolytic multi-target inhibitors with HIF-1α as one of the targets.

Loading

Article metrics loading...

/content/journals/coc/10.2174/1385272823666191203122030
2019-11-01
2025-06-11
Loading full text...

Full text loading...

/content/journals/coc/10.2174/1385272823666191203122030
Loading

  • Article Type:
    Review Article
Keyword(s): anticancer; HIF-1α; hypoxia situation; inhibition; natural flavonoids; signaling pathway
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test